The emerging field of lipidomics

Nature Reviews Drug Discovery

Volumn 4, Issue 7, 2005, Pages 594-610

  Wenk, Markus R ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE INHIBITOR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIVIRUS AGENT; ATORVASTATIN; BIOLOGICAL MARKER; CARDIOLIPIN; CELECOXIB; CERAMIDE; ETHER LIPID; FATTY ACID; FATTY ACID DERIVATIVE; GLYCEROLIPID; GLYCEROPHOSPHOLIPID; LIPID; LIPOSOME; LYSOPHOSPHATIDIC ACID; MEMBRANE LIPID; NEUROPROTECTIVE AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHATIDYLSERINE; PHOSPHOLIPID; PRODRUG; SPHINGOLIPID; STEROL; TETRAHYDROLIPSTATIN; WORTMANNIN;

CANCER; CARBON NUCLEAR MAGNETIC RESONANCE; CATALYSIS; CELL DEATH; CELL GROWTH; CELL MIGRATION; CHROMATOGRAPHY; DEGENERATIVE DISEASE; DIABETES MELLITUS; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; DRUG DELIVERY SYSTEM; DRUG SCREENING; DRUG SYNTHESIS; ENERGY METABOLISM; FLUORESCENCE ANALYSIS; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENOMICS; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; LIPID ANALYSIS; LIPID METABOLISM; MASS SPECTROMETRY; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; MOLECULAR MIMICRY; NONHUMAN; OBESITY; OPTICAL INSTRUMENTATION; OXIDATIVE STRESS; PATHOGENICITY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; PROTEOMICS; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; RISK MANAGEMENT; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS;

ANIMALS; BIOLOGICAL MARKERS; CLINICAL TRIALS; GENOMICS; HUMANS; LIPID METABOLISM; LIPIDS; MOLECULAR BIOLOGY;

EID: 22144478635     PISSN: 14741776     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrd1776     Document Type: Review

References (200)

1. Wilson, J. F. Long-suffering lipids gain respect. The Scientist 17, 34-46 (2003).
2. Lagarde, M., Geloen, A., Record, M., Vance, D. & Spener, F. Lipidomics is emerging. Biochim. Biophys. Acta 1634, 61 (2003).
3. Feng, L. & Prestwich, G.D. (eds) Functional Lipidomics (Dekker-CRC, New York, 2005).
4. Glomset, J. A. Protein lipid interactions on the surfaces of cell membranes. Curr. Opin. Struct. Biol. 9, 425-427 (1999).
5. Scott, D. L. & Sigler, P. B. Structure and catalytic mechanism of secretory phospholipases A2. Adv. Protein Chem. 45, 53-88 (1994).
6. Gelb, M. H., Min, J. H. & Jain, M. K. Do membrane-bound enzymes access their substrates from the membrane or aqueous phase: interfacial versus non-interfacial enzymes. Biochim. Biophys. Acta 1488, 20-27 (2000).
7. Rao, V. D., Misra, S., Boronenkov, I. V., Anderson, R. A. & Hurley, J. H. Structure of type IIbeta phosphatidylinositol phosphate kinase: a protein kinase fold flattened for interfacial phosphorylation. Cell 94, 829-839 (1998).
8. Tsujishita, Y., Guo, S., Stolz, L. E., York, J. D. & Hurley, J. H. Specificity determinants in phosphoinositide dephosphorylation: crystal structure of an archetypal inositol polyphosphate 5-phosphatase. Cell 105, 379-389 (2001).
9. Roberts, M. F. Phospholipases: structural and functional motifs for working at an interface. FASEB J. 10, 1159-1172 (1996).
10. Kunz, J. et al. The activation loop of phosphatidylinositol phosphate kinases determines signaling specificity. Mol. Cells 5, 1-11 (2000).
11. Goni, F. M. & Alonso, A. in Lipases and Phospholipases in Drug Development (eds Muller, G. & Petry, S.) 79-100 (Wiley-VCH, Weinheim, Germany, 2004).
12. Israelachvili, J. N. Refinement of the fluid-mosaic model of membrane structure. Biochim. Biophys. Acta 469, 221-225 (1977).
13. Duzgunes, N., Straubinger, R. M., Baldwin, P. A., Friend, D. S. & Papahadjopoulos, D. Proton-induced fusion of oleic acid-phosphatidylethanolamine liposomes. Biochemistry 24, 3091-3098 (1985).
14. Chernomordik, L., Kozlov, M. M. & Zimmerberg, J. Lipids in biological membrane fusion. J. Membr. Biol. 146, 1-14 (1995).
15. Feigenson, G. W. & Buboltz, J. T. Ternary phase diagram of dipalmitoyl-PC/dilauroyl-PC/cholesterol: nanoscopic domain formation driven by cholesterol. Biophys. J. 80, 2775-2788 (2001).
16. Berridge, M. J. Inositol trisphosphate and calcium signaling. Nature 361, 315-325 (1993).
17. Tanaka, C. & Nishizuka, Y. The protein kinase C family for neuronal signaling. Annu. Rev. Neurosci. 17, 551-567 (1994).
18. Luo, B., Regier, D. S., Prescott, S. M. & Topham, M. K. Diacylglycerol kinases. Cell Signal. 16, 983-989 (2004).
19. Athenstaedt, K. & Daum, G. Phosphatidic acid, a key intermediate in lipid metabolism. Eur. J. Biochem. 266, 1-16 (1999).
20. Shears, S. B. How versatile are inositol phosphate kinases? Biochem. J. 377, 265-280 (2004).
21. Balazy, M. Eicosanomics: targeted lipidomics of eicosanoids in biological systems. Prostaglandins Other Lipid Mediat. 73, 173-180 (2004).
22. Barenholz, Y. Sphingomyelin and cholesterol: from membrane biophysics and rafts to potential medical applications. Subcell. Biochem. 37, 167-215 (2004).
23. Pettus, B. J., Chalfant, C. E. & Hannun, Y. A. Sphingolipids in inflammation: roles and implications. Curr. Mol. Med. 4, 405-418 (2004).
24. Reynolds, C. P., Maurer, B. J. & Kolesnick, R. N. Ceramide synthesis and metabolism as a target for cancer therapy. Cancer Lett. 206, 160-180 (2004).
25. Hla, T. Physiological and pathological actions of sphingosine 1-phosphate. Semin. Cell Dev. Biol. 15, 513-520 (2004).
26. Kee, T. H., Vit, P. & Melendez, A. J. Sphingosine kinase signalling in immune cells. Clin. Exp. Pharmacol. Physiol. 32, 153-161 (2005).
27. Takenawa, T. & Itoh, T. Phosphoinositides, key molecules for regulation of actin cytoskeletal organization and membrane traffic from the plasma membrane. Biochim. Biophys. Acta 1533, 190-206 (2001).
28. Wenk, M. R. & De Camilli, P. Inaugural article: Protein-lipid interactions and phosphoinositide metabolism in membrane traffic: Insights from vesicle recycling in nerve terminals. Proc. Natl Acad. Sci. USA 101, 8262-8269 (2004).
29. Hurley, J. H. & Meyer, T. Subcellular targeting by membrane lipids. Curr. Opin. Cell Biol. 13, 146-152 (2001).
30. Balla, T. & Varnai, P. Visualizing cellular phosphoinositide pools with GFP-fused protein- modules. Sci STKE L3 (2002).
31. van Rossum, D. B. et al. Phospholipase Cγ1 controls surface expression of TRPC3 through an intermolecular PH domain. Nature 434, 99-104 (2005).
32. Godi, A. et al. FAPPs control Golgi-to-cell-surface membrane traffic by binding to ARF and PtdIns(4)P. Nature Cell Biol. 6, 393-404 (2004).
33. Simonsen, A., Wurmser, A. E., Emr, S. D. & Stenmark, H. The role of phosphoinositides in membrane transport. Curr. Opin. Cell Biol. 13, 485-492 (2001).
34. Rudge, S. A., Anderson, D. M. & Emr, S. D. Vacuole size control: regulation of PtdIns(3, 5)P2 levels by the vacuole-associated Vac14-Fig4 complex, a PtdIns(3, 5)P2-specific phosphatase. Mol. Biol. Cell 15, 24-36 (2004).
35. Stone, S. J. et al. Lipopenia and skin barrier abnormalities in DGAT2-deficient mice. J. Biol. Chem. 279, 11767-11776 (2004).
36. Shi, Y. & Burn, P. Lipid metabolic enzymes: emerging drug targets for the treatment of obesity. Nature Rev. Drug Discov. 3, 695-710 (2004).
37. Muller, G. in Lipases and Phospholipases in Drug Development 231-331 (Wiley-VCH, Weinheim, Germany, 2004).
38. Hollander, P. Orlistat in the treatment of obesity. Prim. Care 30, 427-440 (2003).
39. Clement, S. et al. The lipid phosphatase SHIP2 controls insulin sensitivity. Nature 409, 92-97 (2001).
40. Sleeman, M. W. et al. Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity. Nature Med. 11, 199-205 (2005).
41. Cohen, P. et al. Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 297, 240-243 (2002).
42. Watson, R. T. & Pessin, J. E. Intracellular organization of insulin signaling and GLUT4 translocation. Recent Prog. Horm. Res. 56, 175-193 (2001).
43. Roden, M. et al. Mechanism of free fatty acid-induced insulin resistance in humans. J. Clin. Invest 97, 2859-2865 (1996).
44. Anderson, R. G. Joe Goldstein and Mike Brown: from cholesterol homeostasis to new paradigms in membrane biology. Trends Cell Biol. 13, 534-539 (2003).
45. Rawson, R. B. The SREBP pathway - insights from Insigs and insects. Nature Rev. Mol. Cell Biol. 4, 631-640 (2003).
46. Watkins, S. M., Reifsnyder, P. R., Pan, H. J., German, J. B. & Leiter, E. H. Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone. J. Lipid Res. 43, 1809-1817 (2002).
47. Santagata, S. et al. G-protein signaling through tubby proteins. Science 292, 2041-2050 (2001).
48. Carroll, K., Gomez, C. & Shapiro, L. Tubby proteins: the plot thickens. Nature Rev. Mol. Cell Biol. 5, 55-63 (2004).
49. Auger, K. R., Serunian, L. A., Soltoff, S. P., Libby, P. & Cantley, L. C. PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells. Cell 57, 167-175 (1989).
50. Czech, M. P. Dynamics of phosphoinositides in membrane retrieval and insertion. Annu. Rev. Physiol. 65, 791-815 (2003).
51. Maehama, T. & Dixon, J. E. The tumor suppressor, PTEN/MMAC1, delphosphorylates the lipid second messenger, phosphatidylinositol 3, 4, 5-trisphosphate. J. Biol. Chem. 273, 13375-13378 (1998).
52. Pendaries, C., Tronchere, H., Plantavid, M. & Payrastre, B. Phosphoinositide signaling disorders in human diseases. FEBS Lett. 546, 25-31 (2003).
53. Giannakou, M. E. et al. Long-lived Drosophila with overexpressed dFOXO in adult fat body. Science 305, 361 (2004).
54. Finan, P. M. & Thomas, M. J. PI 3-kinase inhibition: a therapeutic target for respiratory disease. Biochem. Soc. Trans. 32, 378-382 (2004).
55. Fruman, D. A. Towards an understanding of isoform specificity in phosphoinositide 3-kinase signalling in lymphocytes. Biochem. Soc. Trans. 32, 315-319 (2004).
56. Schmid, A. C. & Woscholski, R. Phosphatases as small-molecule targets: inhibiting the endogenous inhibitors of kinases. Biochem. Soc. Trans. 32, 348-349 (2004).
57. Wetzker, R. & Rommel, C. Phosphoinositide 3-kinases as targets for therapeutic intervention. Curr. Pharm. Des 10, 1915-1922 (2004).
58. Heinrich, M. et al. Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and-3 activation. Cell Death. Differ. 11, 550-563 (2004).
59. Bose, R. et al. Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 82, 405-414 (1995).
60. Ogretmen, B. & Hannun, Y. A. Biologically active sphingolipids in cancer pathogenesis and treatment. Nature Rev. Cancer 4, 604-616 (2004).
61. Xia, P. et al. An oncogenic role of sphingosine kinase. Curr. Biol. 10, 1527-1530 (2000).
62. Liu, F. et al. Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis. Involvement of G(ialpha2)-linked Rho kinase activity. Am. J. Respir. Cell Mol. Biol. 24, 711-719 (2001).
63. Corda, D., Iurisci, C. & Berrie, C. P. Biological activities and metabolism of the lysophosphoinositides and glycerophosphoinositols. Biochim. Biophys. Acta 1582, 52-69 (2002).
64. Hideshima, T. et al. Antitumor activity of lysophosphatidic acid acyltransferase-beta inhibitors, a novel class of agents, in multiple myeloma. Cancer Res. 63, 8428-8436 (2003).
65. Basler, J. W. & Piazza, G. A. Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective inhibitors for prostate cancer chemoprevention. J. Urol. 171, S59-S62 (2004).
66. Cremona, O. & De Camilli, P. Phosphoinositides in membrane traffic at the synapse. J. Cell. Sci. 114, 1041-1052 (2001).
67. Cutler, R. G. et al. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc. Natl Acad. Sci. USA 101, 2070-2075 (2004).
68. Yanagisawa, K., Odaka, A., Suzuki, N. & Ihara, Y. GM1 ganglioside-bound amyloid beta-protein (A beta): a possible form of preamyloid in Alzheimer's disease. Nature Med. 1, 1062-1066 (1995).
69. Perrin, R. J., Woods, W. S., Clayton, D. F. & George, J. M. Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins. J. Biol. Chem. 276, 41958-41962 (2001).
70. Sharon, R. et al. The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease. Neuron 37, 583-595 (2003).
71. Lwin, A., Orvisky, E., Goker-Alpan, O., LaMarca, M. E. & Sidransky, E. Glucocerebrosidase mutations in subjects with parkinsonism. Mol. Genet. Metab 81, 70-73 (2004).
72. Pentchev, P. G. et al. A defect in cholesterol esterification in Niemann-Pick disease (type C) patients. Proc. Natl Acad. Sci. USA 82, 8247-8251 (1985).
73. Sturley, S. L., Patterson, M. C., Balch, W. & Liscum, L. The pathophysiology and mechanisms of NP-C disease. Biochim. Biophys. Acta 1685, 83-87 (2004).
74. Selkoe, D. J. Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases. Nature Cell Biol. 6, 1054-1061 (2004).
75. Stebbins, C. E. & Galan, J. E. Structural mimicry in bacterial virulence. Nature 412, 701-705 (2001).
76. Walburger, A. et al. Protein kinase G from pathogenic mycobacteria promotes survival within macrophages. Science 304, 1800-1804 (2004).
77. Poltorak, A. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085-2088 (1998).
78. Akira, S. & Takeda, K. Toll-like receptor signalling. Nature Rev. Immunol. 4, 499-511 (2004).
79. Jahn, R., Lang, T. & Sudhof, T. C. Membrane fusion. Cell 112, 519-533 (2003).
80. Simons, K. & Ikonen, E. Functional rafts in cell membranes. Nature 387, 569-572 (1997).
81. Kobayashi, T. et al. A lipid associated with the antiphospholipid syndrome regulates endosome structure and function. Nature 392, 193-197 (1998).
82. Anderson, R. G. & Jacobson, K. A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains. Science 296, 1821-1825 (2002).
83. Gatfield, J. & Pieters, J. Essential role for cholesterol in entry of mycobacteria into macrophages. Science 288, 1647-1650 (2000).
84. Ono, A., Ablan, S. D., Lockett, S. J., Nagashima, K. & Freed, E. O. Phosphatidylinositol (4, 5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc. Natl Acad. Sci. USA 101, 14889-14894 (2004).
85. Lindwasser, O. W. & Resh, M. D. Multimerization of human immunodeficiency virus type 1 Gag promotes its localization to barges, raft-like membrane microdomains. J. Virol. 75, 7913-7924 (2001).
86. Nguyen, D. H. & Hildreth, J. E. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J. Virol. 74, 3264-3272 (2000).
87. Finnegan, C. M. et al. Ceramide, a target for antiretroviral therapy. Proc. Natl Acad. Sci. USA 101, 15452-15457 (2004).
88. Scheiffele, P., Rietveld, A., Wilk, T. & Simons, K. Influenza viruses select ordered lipid domains during budding from the plasma membrane. J. Biol. Chem. 274, 2038-2044 (1999).
89. Campbell, S. M., Crowe, S. M. & Mak, J. Virion-associated cholesterol is critical for the maintenance of HIV-1 structure and infectivity. AIDS 16, 2253-2261 (2002).
90. Morris-Natschke, S. L., Ishaq, K. S. & Kucera, L. S. Phospholipid analogs against HIV-1 infection and disease. Curr. Pharm. Des. 9, 1441-1451 (2003).
91. Raulin, J. Human immunodeficiency virus and host cell lipids. Interesting pathways in research for a new HIV therapy. Prog. Lipid. Res. 41, 27-65 (2002).
92. Vergne, I., Chua, J. & Deretic, V. Tuberculosis toxin blocking phagosome maturation inhibits a novel Ca2+/calmodulin-PI3K hVPS34 cascade. J. Exp. Med. 198, 653-659 (2003).
93. Rhoades, E. et al. Identification and macrophage-activating activity of glycolipids released from intracellular Mycobacterium bovis BCG. Mol. Microbiol. 48, 875-888 (2003).
94. Fratti, R. A., Chua, J., Vergne, I. & Deretic, V. Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest. Proc. Natl Acad. Sci. USA 100, 5437-5442 (2003).
95. Hernandez, L. D., Hueffer, K., Wenk, M. R. & Galan, J. E. Salmonella modulates vesicular traffic by altering phosphoinositide metabolism. Science 304, 1805-1807 (2004).
96. Converse, S. E. et al. MmpL8 is required for sulfolipid-1 biosynthesis and Mycobacterium tuberculosis virulence. Proc. Natl Acad. Sci. USA 100, 6121-6126 (2003).
97. Thompson, C. R. et al. Sphingosine kinase 1 (SK1) is recruited to nascent phagosomes in human macrophages: inhibition of SK1 translocation by Mycobacterium tuberculosis. J. Immunol. 174, 3551-3561 (2005).
98. Mota, L. J., Journet, L., Sorg, I., Agrain, C. & Cornelis, G. R. Bacterial injectisomes: needle length does matter. Science 307, 1278 (2005).
99. Vergne, I. et al. Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 102, 4033-4038 (2005).
100. Steele-Mortimer, O. et al. Activation of Akt/protein kinase B in epithelial cells by the Salmonella typhimurium effector sigD. J. Biol. Chem. 275, 37718-37724 (2000).
101. Porcelli, S. et al. Recognition of cluster of differentiation 1 antigens by human CD4-CD8-cytolytic T lymphocytes. Nature 341, 447-450 (1989).
102. Sieling, P. A. et al. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 269, 227-230 (1995).
103. Brigl, M. & Brenner, M. B. CD1: Antigen presentation and T cell function. Annu. Rev. Immunol. 22, 817-890 (2004).
104. Hava, D. L. et al. CD1 assembly and the formation of CD1-antigen complexes. Curr. Opin. Immunol. 17, 88-94 (2005).
105. Winau, F. et al. Saposin C is required for lipid presentation by human CD1b. Nature Immunol. 5, 169-174 (2004).
106. Park, J. J. et al. Lipid-protein interactions: biosynthetic assembly of CD1 with lipids in the endoplasmic reticulum is evolutionarily conserved. Proc. Natl Acad. Sci. USA 101, 1022-1026 (2004).
107. Han, X. & Gross, R. W. Electrospray ionization mass spectroscopic analysis of human erythrocyte plasma membrane phospholipids. Proc. Natl Acad. Sci. USA 91, 10635-10639 (1994).
108. Kim, H. Y. Wang, T C. & Ma, Y. C. Liquid chromatography/mass spectrometry of phospholipids using electrospray ionization. Anal. Chem. 66, 3977-3982 (1994).
109. Kerwin, J. L., Tuininga, A. R. & Ericsson, L. H. Identification of molecular species of glycerophospholipids and sphingomyelin using electrospray mass spectrometry. J. Lipid. Res. 35, 1102-1114 (1994).
110. Pulfer, M. & Murphy, R. C. Electrospray mass spectrometry of phospholipids. Mass Spectrom. Rev. 22, 332-364 (2003).
111. Han, X. & Gross, R. W. Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI/MS: a bridge to lipidomics. J. Lipid. Res. 44, 1071-1079 (2003).
112. Welti, R. & Wang, X. Lipid species profiling: a high-throughput approach to identify lipid compositional changes and determine the function of genes involved in lipid metabolism and signaling. Curr. Opin. Plant Biol. 7, 337-344 (2004).
113. Brugger, B., Erben, G., Sandhoff, R., Wieland, F. T. & Lehmann, W. D. Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry. Proc. Natl Acad. Sci. USA 94, 2339-2344 (1997).
114. Sullards, M. C. & Merrill, A. H., Jr. Analysis of sphingosine 1-phosphate, ceramides, and other bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Sci STKE PL1 (2001).
115. Han, X. & Gross, R. W. Quantitative analysis and molecular species fingerprinting of triacylglyceride molecular species directly from lipid extracts of biological samples by electrospray ionization tandem mass spectrometry. Anal. Biochem. 295, 88-100 (2001).
116. Ivanova, P. T. et al. Electrospray ionization mass spectrometry analysis of changes in phospholipids in RBL-2H3 mastocytoma cells during degranulation. Proc. Natl Acad. Sci. USA 98, 7152-7157 (2001).
117. Han, X., Yang, J., Cheng, H., Ye, H. & Gross, R. W. Toward fingerprinting cellular lipidomes directly from biological samples by two-dimensional electrospray ionization mass spectrometry. Anal. Biochem. 330, 317-331 (2004).
118. Ekroos, K., Chernushevich, I. V., Simons, K. & Shevchenko, A. Quantitative profiling of phospholipids by multiple precursor ion scanning on a hybrid quadrupole time-of-flight mass spectrometer. Anal. Chem. 74, 941-949 (2002).
119. Schaub, T. M., Hendrickson, C. L., Qian, K., Quinn, J. P. & Marshall, A. G. High-resolution field desorption/ionization fourier transform ion cyclotron resonance mass analysis of nonpolar molecules. Anal. Chem. 75, 2172-2176 (2003).
120. Wenk, M. R. et al. Phosphoinositide profiling in complex lipid mixtures using electrospray ionization mass spectrometry. Nature Biotechnol. 21, 813-817 (2003).
121. Han, X. Characterization and direct quantitation of ceramide molecular species from lipid extracts of biological samples by electrospray ionization tandem mass spectrometry. Anal. Biochem. 302, 199-212 (2002).
122. Ivleva, V. B. et al. Coupling thin-layer chromatography with vibrational cooling matrix-assisted laser desorption/ionization Fourier transform mass spectrometry for the analysis of ganglioside mixtures. Anal. Chem. 76, 6484-6491 (2004).
123. Welti, R. et al. Profiling membrane lipids in plant stress responses. Role of phospholipase D alpha in freezing-induced lipid changes in Arabidopsis. J. Biol. Chem. 277, 31994-32002 (2002).
124. Koivusalo, M., Haimi, P., Heikinheimo, L., Kostiainen, R. & Somerharju, P. Quantitative determination of phospholipid compositions by ESI-MS: effects of acyl chain length, unsaturation, and lipid concentration on instrument response. J. Lipid. Res. 42, 663-672 (2001).
125. Petkovic, M. et al. Detection of individual phospholipids in lipid mixtures by matrix- assisted laser desorption/ionization time-of-flight mass spectrometry: phosphatidylcholine prevents the detection of further species. Anal. Biochem. 289, 202-216 (2001).
126. Muller, M. et al. Limits for the detection of (poly)phosphoinositides by matrix-assisted laser desorption and ionization time-of-flight mass spectrometry (MALDI-TOF MS). Chem. Phys. Lipids 110, 151-164 (2001).
127. Houjou, T., Yamatani, K., Imagawa, M., Shimizu, T. & Taguchi, R. A shotgun tandem mass spectrometric analysis of phospholipids with normal-phase and/or reverse-phase liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun. Mass Spectrom. 19, 654-666 (2005).
128. Hermansson, M., Uphoff, A., Kakela, R. & Somerharju, P. Automated quantitative analysis of complex lipidomes by liquid chromatography/mass spectrometry. Anal. Chem. 77, 2166-2175 (2005).
129. Watkins, S. M. Lipomic profiling in drug discovery, development and clinical trial evaluation. Curr. Opin. Drug Discov. Devel. 7, 112-117 (2004).
130. Picchioni, G. A., Watada, A. E. & Whitaker, B. D. Quantitative high-performance liquid chromatography analysis of plant phospholipids and glycolipids using light-scattering detection. Lipids 31, 217-221 (1996).
131. Nasuhoglu, C. et al. Nonradioactive analysis of phosphatidylinositides and other anionic phospholipids by anion-exchange high-performance liquid chromatography with suppressed conductivity detection. Anal. Biochem. 301, 243-254 (2002).
132. Lin, S., Fischl, A. S., Bi, X. & Parce, W. Separation of phospholipids in microfluidic chip device: application to high-throughput screening assays for lipid-modifying enzymes. Anal. Biochem. 314, 97-107 (2003).
133. Qi, L., Danielson, N. D., Dai, Q. & Lee, R. M. Capillary electrophoresis of cardiolipin with on-line dye interaction and spectrophotometric detection. Electrophoresis 24, 1680-1686 (2003).
134. German, J. B., Roberts, M. A. & Watkins, S. M. Personal metabolomics as a next generation nutritional assessment. J. Nutr. 133, 4260-4266 (2003).
135. Adams, A. & Kingsbury, J. Lipomic profiling, profiled. Modern Drug Discov. 55-56 (2004).
136. Seelig, A. & Seelig, J. Effect of a single cis double bond on the structures of a phospholipid bilayer. Biochemistry 16, 45-50 (1977).
137. Gawrisch, K., Eldho, N. V. & Polozov, I. V. Novel NMR tools to study structure and dynamics of biomembranes. Chem. Phys. Lipids 116, 135-151 (2002).
138. Marsh, D. & Pali, T. The protein-lipid interface: perspectives from magnetic resonance and crystal structures. Biochim. Biophys. Acta 1666, 118-141 (2004).
139. Marsh, D. & Barrantes, F. J. Immobilized lipid in acetylcholine receptor-rich membranes from Torpedo marmorata. Proc. Natl Acad. Sci. USA 75, 4329-4333 (1978).
140. Hilgemann, D. W., Feng, S. & Nasuhoglu, C. The complex and intriguing lives of PIP2 with ion channels and transporters. Sci. STKE. RE19 (2001).
141. Fu, R. & Cross, T. A. Solid-state nuclear magnetic resonance investigation of protein and polypeptide structure. Annu. Rev. Biophys. Biomol. Struct. 28, 235-268 (1999).
142. Gavaghan, C. L., Holmes, E., Lenz, E., Wilson, I. D. & Nicholson, J. K. An NMR-based metabonomic approach to investigate the biochemical consequences of genetic strain differences: application to the C57BL10J and Alpk: ApfCD mouse. FEBS Lett. 484, 169-174 (2000).
143. Nicholson, J. K. & Wilson, I. D. Opinion: understanding 'global' systems biology: metabonomics and the continuum of metabolism. Nature Rev. Drug Discov. 2, 668-676 (2003).
144. Prestwich, G. D. Phosphoinositide signaling; from affinity probes to pharmaceutical targets. Chem. Biol. 11, 619-637 (2004).
145. Taylor, G. S. & Dixon, J. E. Assaying phosphoinositide phosphatases. Methods Mol. Biol. 284, 217-228 (2004).
146. Zhu, H. et al. Global analysis of protein activities using proteome chips. Science 293, 2101-2105 (2001).
147. Mukherjee, S. & Maxfield, F. R. Role of membrane organization and membrane domains in endocytic lipid trafficking. Traffic 1, 203-211 (2000).
148. Kol, M. A., de Kroon, A. I., Killian, J. A. & de, K. B. Transbilayer movement of phospholipids in biogenic membranes. Biochemistry 43, 2673-2681 (2004).
149. Wenk, M. R. & De Camilli, P. Assembly of endocytosis-associated proteins on liposomes. Meth. Enzymol. 372, 248-260 (2003).
150. Krugmann, S. et al. Identification of ARAP3, a novel PI3K effector regulating both Arf and Rho GTPases, by selective capture on phosphoinositide affinity matrices. Mol. Cell 9, 95-108 (2002).
151. Kolusheva, S., Boyer, L. & Jelinek, R. A colorimetric assay for rapid screening of antimicrobial peptides. Nature Biotechnol. 18, 225-227 (2000).
152. Botelho, R. J. et al. Localized biphasic changes in phosphatidylinositol-4, 5-bisphosphate at sites of phagocytosis. J. Cell Biol. 151, 1353-1368 (2000).
153. Bligh, E. G. & Dyer, W. J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911-917 (1959).
154. Folch, J., Ascoli, I., Lees, M., Meath, J. A. & Le, B. N. Preparation of lipide extracts from brain tissue. J. Biol. Chem. 191, 833-841 (1951).
155. Wenk, M. R. & De Camilli, P. in Functional Lipidomics (eds. Feng, L. & Prestwich, G. D.) (Dekker-CRC, New York, in the press).
156. Fahy, E. et al. A comprehensive classification system for lipids. J. Lipid Res. 46, 839-862 (2005).
157. Forrester, J. S., Milne, S. B., Ivanova, P. T. & Brown, H. A. Computational lipidomics: a multiplexed analysis of dynamic changes in membrane lipid composition during signal transduction. Mol. Pharmacol. 65, 813-821 (2004).
158. Lu, Y., Hong, S., Tjonahen, E. & Serhan, C. N. Mediator-lipidomics: databases and search algorithms for PUFA-derived mediators. J. Lipid Res. 46, 790-802 (2005).
159. varez-Vasquez, F. et al. Simulation and validation of modelled sphingolipid metabolism in Saccharomyces cerevisiae. Nature 433, 425-430 (2005).
160. Vance, D. E. & Vance, J. E. (eds) Biochemistry of Lipids, Lipoproteins and Membranes (Elsevier, New York, 2001).
161. Lemmon, M. A. Pleckstrin homology domains: not just for phosphoinositides. Biochem. Soc. Trans. 32, 707-711 (2004).
162. Weckwerth, W., Loureiro, M. E., Wenzel, K. & Fiehn, O. Differential metabolic networks unravel the effects of silent plant phenotypes. Proc. Natl Acad. Sci. USA 101, 7809-7814 (2004).
163. Cascante, M. et al. Metabolic control analysis in drug discovery and disease. Nature Biotechnol. 20, 243-249 (2002).
164. Hodgkin, M. N. et al. Diacylglycerols and phosphatidates: which molecular species are intracellular messengers? Trends Biochem. Sci. 23, 200-204 (1998).
165. Gronert, K. et al. A molecular defect in intracellular lipid signaling in human neutrophils in localized aggressive periodontal tissue damage. J. Immunol. 172, 1856-1861 (2004).
166. Kroesen, B. J. et al. Induction of apoptosis through B-cell receptor cross-linking occurs via de novo generated C16-ceramide and involves mitochondria. J. Biol. Chem. 276, 13606-13614 (2001).
167. Koybasi, S. et al. Defects in cell growth regulation by C18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas. J. Biol. Chem. 279, 44311-44319 (2004).
168. Alaimo, P. J., Shogren-Knaak, M. A. & Shokat, K. M. Chemical genetic approaches for the elucidation of signaling pathways. Curr. Opin. Chem. Biol. 5, 360-367 (2001).
169. Zewail, A. et al. Novel functions of the phosphatidylinositol metabolic pathway discovered by a chemical genomics screen with wortmannin. Proc. Natl Acad. Sci. USA 100, 3345-3350 (2003).
170. Boshoff, H. I. et al. The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action. J. Biol. Chem. 279, 40174-40184 (2004).
171. Moody, D. B. et al. T cell activation by lipopeptide antigens. Science 303, 527-531 (2004).
172. Hoebe, K. et al. CD36 is a sensor of diacylglycerides. Nature 433, 523-527 (2005).
173. Matsuda, L. A,, Lolait, S. J., Brownstein, M. J., Young, A. C. & Bonner, T. I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564 (1990).
174. Devane, W. A. et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949 (1992).
175. McFarland, M. J. & Barker, E. L. Anandamide transport. Pharmacol. Ther. 104, 117-135 (2004).
176. Hamman, B. D., Pollok, B. A., Bennett, T., Allen, J. & Heim, R. Binding of a Pleckstrin homology domain protein to phosphoinositide in membranes: a miniaturized FRET-based assay for drug screening. J. Biomol. Screen. 7, 45-55 (2002).
177. Gray, A., Olsson, H., Batty, I. H., Priganica, L. & Peter Downes, C. Nonradioactive methods for the assay of phosphoinositide 3-kinases and phosphoinositide phosphatases and selective detection of signaling lipids in cell and tissue extracts. Anal. Biochem. 313, 234-245 (2003).
178. Saghatelian, A. et al. Assignment of endogenous substrates to enzymes by global metabolite profiling. Biochemistry 43, 14332-14339 (2004).
179. Cicchetti, G., Biernacki, M., Farquharson, J. & Allen, P. G. A ratiometric expressible FRET sensor for phosphoinositides displays a signal change in highly dynamic membrane structures in fibroblasts. Biochemistry 43, 1930-1949 (2004).
180. Tanimura, A., Nezu, A., Morita, T., Turner, R. J. & Tojyo, Y. Fluorescent biosensor for quantitative real-time measurements of inositol 1, 4, 5-trisphosphate in single living cells. J. Biol. Chem. 279, 38095-38098 (2004).
181. Nieland, T. J. et al. Chemical genetic screening identifies sulfonamides that raise organellar pH and interfere with membrane traffic. Traffic. 5, 478-492 (2004).
182. Rudolf, M. T., Dinkel, C., Traynor-Kaplan, A. E. & Schultz, C. Antagonists of myo-inositol 3, 4, 5, 6-tetrakisphosphate allow repeated epithelial chloride secretion. Bioorg. Med. Chem. 11, 3315-3329 (2003).
183. Saiardi, A., Bhandari, R., Resnick, A. C., Snowman, A. M. & Snyder, S. H. Phosphorylation of proteins by inositol pyrophosphates. Science 306, 2101-2105 (2004).
184. Andresen, T. L., Davidsen, J,, Begtrup, M., Mouritsen, O. G. & Jorgensen, K. Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs. J. Med. Chem. 47, 1694-1703 (2004).
185. Chithalen, J. V., Luu, L., Petkovich, M. & Jones, G. HPLC-MS/MS analysis of the products generated from all-trans-retinoic acid using recombinant human CYP26A. J. Lipid Res. [b 43, 1133-1142 (2002).
186. Robertson, D. G. Metabonomics in toxicology: a review. Toxicol. Sci. 85, 809-822 (2005).
187. Butterfield, D. A. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radic. Res. 36, 1307-1313 (2002).
188. Montine, K. S. et al. Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases. Chem. Phys. Lipids 128, 117-124 (2004).
189. Basu, S., Whiteman, M., Mattey, D. L. & Halliwell, B. Raised levels of F(2)-isoprostanes and prostaglandin F(2alpha) in different rheumatic diseases. Ann. Rheum. Dis. 60, 627-631 (2001).
190. Spickett, C. M., Pitt, A. R. & Brown, A. J. Direct observation of lipid hydroperoxides in phospholipid vesicles by electrospray mass spectrometry. Free Radic. Biol. Med. 25, 613-620 (1998).
191. Ishida, M. et al. High-resolution analysis by nano-electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry for the identification of molecular species of phospholipids and their oxidized metabolites. Rapid Commun. Mass Spectrom. 18, 2486-2494 (2004).
192. Leitinger, N. et al. Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils. Proc. Natl Acad. Sci. USA 96, 12010-12015 (1999).
193. Lutter, M. et al. Cardiolipin provides specificity for targeting of tBid to mitochondria. Nature Cell Biol. 2, 754-761 (2000).
194. Kagan, V. E. et al. A role for oxidative stress in apoptosis: oxidation and externalization of phosphatidylserine is required for macrophage clearance of cells undergoing Fas-mediated apoptosis. J. Immunol. 169, 487-499 (2002).
195. Bannenberg, G. L. et al. Molecular circuits of resolution: formation and actions of resolvins and protectins. J. Immunol. 174, 4345-4355 (2005).
196. Pravdova, V., Walczak, B. & Massart, D. L. A comparison of two algorithms for warping of analytical signals. Anal. Chim. Acta 456, 77-92 (2002).
197. Weckwerth, W. Metabolomics in systems biology. Annu. Rev. Plant Physiol. Plant Mol. Biol. 54, 669-689 (2003).
198. McLaughlin, S., Wang, J,, Gambhir, A. & Murray, D. PIP(2) and proteins: interactions, organization, and information flow. Annu. Rev. Biophys. Biomol. Struct. 31, 151-175 (2002).
199. Barrantes, F. J. Structural basis for lipid modulation of nicotinic acetylcholine receptor function. Brain Res. Brain Res. Rev. 47, 71-95 (2004).
200. Lemmon, M. A. Phosphoinositide recognition domains. Traffic 4, 201-213 (2003).